Your session is about to expire
← Back to Search
Diagnostic Arthroscopy using the Arthrex NanoScope for Wrist arthritis
N/A
Waitlist Available
Led By Nader Paksima
Research Sponsored by NYU Langone Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1
Awards & highlights
No Placebo-Only Group
Summary
This trial tests the Arthrex NanoScope, a small camera used in wrist surgeries, on patients with wrist issues. The camera helps doctors see inside the wrist joint to diagnose problems and decide on treatments.
Eligible Conditions
- Wrist arthritis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 1
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Surgeon-Rated Midcarpal Visualization With Arthrex Nanoscope
Surgeon-Rated Midcarpal Visualization With Conventional Instrument
Surgeon-Rated Radiocarpal Visualization With Arthrex Nanoscope
+1 moreSecondary study objectives
Surgeon-rated Confidence in Arthrex NanoScope Diagnosis
Surgeon-rated Confidence in Conventional Instrument Diagnosis
Surgeon-rated Ease of Use of Arthrex NanoScope
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Experimental CohortExperimental Treatment2 Interventions
Patients with clinically diagnosed wrist pathology undergoing wrist arthroscopy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Diagnostic Arthroscopy using the Arthrex NanoScope
2020
N/A
~20
Diagnostic Arthroscopy using standard arthroscopic instruments
2020
N/A
~20
Find a Location
Who is running the clinical trial?
NYU Langone HealthLead Sponsor
1,409 Previous Clinical Trials
855,795 Total Patients Enrolled
Nader PaksimaPrincipal InvestigatorNYU Langone Health
1 Previous Clinical Trials
23 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger